PT  - JOURNAL ARTICLE
AU  - Juri Smirnov
AU  - Thomas Fenner
TI  - Dynamical Pool-Size Optimization for the SARS-CoV-2 PCR Test
AID  - 10.1101/2021.01.12.21249581
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.12.21249581
4099  - http://medrxiv.org/content/early/2021/01/15/2021.01.12.21249581.short
4100  - http://medrxiv.org/content/early/2021/01/15/2021.01.12.21249581.full
AB  - In this work, we put forward a novel test strategy, that allows to significantly increase the test capacity for SARS-CoV-2. The test strategy is based on an a priory risk assessment scheme, that allows to dynamically find and adapt an optimal clustering size of test pools. We, furthermore, suggest a method to overcome the efficiency loss of test clustering by avoiding concentration losses in the test samples. We validated our method with several thousand probe pools performing RT-PCR tests, and found it highly effective.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work of J.S. is largely Funded by the Alexander von Humboldt foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data of the study only contain PCR cycle values obtained in the routine diagnostic in the Institute for Clinical Pathology Dr. Fenner and Colleagues, which is accredited by the German Norm DIN EN ISO 15189.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesExternal data for cycle values have been used from this source: He, X., Lau, E.H.Y., Wu, P. et al. Temporal dynamics in viral shedding and transmissibility of COVID 19. Nat Med 26, 672 675 (2020). https://doi.org/10.1038/s41591-020-0869-5